Applied Genetic Technologies reported $37.24M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Alimera Sciences ALIM:US USD 29.76M 3.31M
Applied Genetic Technologies AGTC:US USD 37.24M 12.32M
Avrobio Inc AVRO:US USD 126.23M 15.85M
Biogen BIIB:US USD 9.77B 24.9M
Bluebird Bio BLUE:US USD 160.44M 7.02M
Celldex Therapeutics CLDX:US USD 334.6M 33.38M
Cti Biopharma CTIC:US USD 96.94M 10.44M
Gilead Sciences GILD:US USD 13.9B 723M
Insmed INSM:US USD 632.16M 42.56M
Intercept Pharmaceuticals ICPT:US USD 545.37M 58.36M
Life Technologies LIFE:US USD 84.63M 8.72M
Ophthotech OPHT:US USD 329.48M 12.26M
Regeneron Pharmaceuticals REGN:US USD 15.43B 101.3M
Rigel Pharmaceuticals RIGL:US USD 110.44M 10.08M
Ultragenyx Pharmaceutical RARE:US USD 1.01B 334.13M